Anti-PD-L1 antibody ASC22 in combination with a histone deacetylase inhibitor chidamide as a "shock and kill" strategy for ART-free virological control: a phase II single-arm study
抗PD-L1抗体ASC22联合组蛋白去乙酰化酶抑制剂西达米德作为“冲击和清除”策略，用于在不使用抗逆转录病毒疗法的情况下控制病毒学：一项II期单臂研究
期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-024-01943-9
Wu, Luling; Zheng, Zhihang; Xun, Jingna; Liu, Li; Wang, Jiangrong; Zhang, Xinyu; Shao, Yueming; Shen, Yinzhong; Zhang, Renfang; Zhang, Min; Sun, Meiyan; Qi, Tangkai; Wang, Zhenyan; Xu, Shuibao; Song, Wei; Tang, Yang; Zhao, Bihe; Song, Zichen; Routy, Jean-Pierre; Lu, Hongzhou; Chen, Jun
